115 related articles for article (PubMed ID: 6716398)
1. Synthesis of pyridine derivatives of L-phenylalanine as antisickling reagents.
Altman J; Gorecki M; Wilchek M; Votano JR; Rich A
J Med Chem; 1984 May; 27(5):596-600. PubMed ID: 6716398
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell Disease.
Xu GG; Pagare PP; Ghatge MS; Safo RP; Gazi A; Chen Q; David T; Alabbas AB; Musayev FN; Venitz J; Zhang Y; Safo MK; Abdulmalik O
Mol Pharm; 2017 Oct; 14(10):3499-3511. PubMed ID: 28858508
[TBL] [Abstract][Full Text] [Related]
3. Potential use of biaromatic L-phenylalanyl derivatives as therapeutic agents in the treatment of sickle cell disease.
Votano JR; Altman J; Wilchek M; Gorecki M; Rich A
Proc Natl Acad Sci U S A; 1984 May; 81(10):3190-4. PubMed ID: 6587344
[TBL] [Abstract][Full Text] [Related]
4. Mode of transport and possible mechanism of action of L-phenylalanine benzyl ester as an anti-sickling agent.
Acquaye CT; Young JD; Ellory JC; Gorecki M; Wilchek M
Biochim Biophys Acta; 1982 Dec; 693(2):407-16. PubMed ID: 7159585
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and testing of potential antisickling agents. 6. Rheologic studies with active phenoxy and benzyloxy acids.
Patwa DC; Abraham DJ; Hung TC
Blood Cells; 1987; 12(3):589-601. PubMed ID: 3651614
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and testing of potential antisickling agents. 9. Cyclic tetrapeptide homologs as mimics of the mutation site of hemoglobin S.
Sheh L; Mokotoff M; Abraham DJ
Int J Pept Protein Res; 1987 Apr; 29(4):509-20. PubMed ID: 3596902
[TBL] [Abstract][Full Text] [Related]
7. Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease.
Pagare PP; Ghatge MS; Musayev FN; Deshpande TM; Chen Q; Braxton C; Kim S; Venitz J; Zhang Y; Abdulmalik O; Safo MK
Bioorg Med Chem; 2018 May; 26(9):2530-2538. PubMed ID: 29655608
[TBL] [Abstract][Full Text] [Related]
8. Survival rates and properties of sickle cell anemia red cells treated with nitrogen mustard.
Roth EF; Wenz B; Lee HB; Fabry M; Chang H; Kaul DK; Baez S; Nagel RL
Prog Clin Biol Res; 1987; 240():245-61. PubMed ID: 3615491
[TBL] [Abstract][Full Text] [Related]
9. Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillin.
Abdulmalik O; Ghatge MS; Musayev FN; Parikh A; Chen Q; Yang J; Nnamani I; Danso-Danquah R; Eseonu DN; Asakura T; Abraham DJ; Venitz J; Safo MK
Acta Crystallogr D Biol Crystallogr; 2011 Nov; 67(Pt 11):920-8. PubMed ID: 22101818
[TBL] [Abstract][Full Text] [Related]
10. Non-uniformity of intracellular polymer formation in sickle erythrocytes: possible correlation with severity of hemolytic anemia.
Noguchi CT; Schechter AN
Am J Pediatr Hematol Oncol; 1984; 6(1):46-50. PubMed ID: 6711762
[TBL] [Abstract][Full Text] [Related]
11. In vitro effects of NIPRISAN (Nix-0699): a naturally occurring, potent antisickling agent.
Iyamu EW; Turner EA; Asakura T
Br J Haematol; 2002 Jul; 118(1):337-43. PubMed ID: 12100171
[TBL] [Abstract][Full Text] [Related]
12. Antisickling activity of amino acid benzyl esters.
Gorecki M; Acquaye CT; Wilchek M; Votano JR; Rich A
Proc Natl Acad Sci U S A; 1980 Jan; 77(1):181-5. PubMed ID: 6928612
[TBL] [Abstract][Full Text] [Related]
13. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
[TBL] [Abstract][Full Text] [Related]
14. Targeting βCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects.
Kassa T; Strader MB; Nakagawa A; Zapol WM; Alayash AI
Metallomics; 2017 Sep; 9(9):1260-1270. PubMed ID: 28770911
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and testing of antisickling agents. 2. Proline derivatives designed for the donor site.
Abraham DJ; Mokotoff M; Sheh L; Simmons JE
J Med Chem; 1983 Apr; 26(4):549-54. PubMed ID: 6834388
[TBL] [Abstract][Full Text] [Related]
16. The effect of phenylalanine derivatives on the solubility of deoxyhemoglobin S. A model class of gelation inhibitors.
Noguchi CT; Ackerman S; DiMaio J; Schiller PW; Schechter AN
Mol Pharmacol; 1983 Jan; 23(1):100-3. PubMed ID: 6865893
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.
Safo MK; Abdulmalik O; Danso-Danquah R; Burnett JC; Nokuri S; Joshi GS; Musayev FN; Asakura T; Abraham DJ
J Med Chem; 2004 Sep; 47(19):4665-76. PubMed ID: 15341482
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and testing of potential antisickling agents. 10. (2,2-Dimethylchroman-6-yl)alkanoic acids.
Fatope MO; Abraham DJ
J Med Chem; 1987 Nov; 30(11):1973-7. PubMed ID: 3669005
[TBL] [Abstract][Full Text] [Related]
19. Sickling-suppressive effects of chrysin may be associated with sequestration of deoxy-haemoglobin, 2,3-bisphosphoglycerate mutase, alteration of redox homeostasis and functional chemistry of sickle erythrocytes.
Muhammad A; Waziri AD; Forcados GE; Sanusi B; Sani H; Malami I; Abubakar IB; Muhammad A; Muhammad RA; Mohammed HA
Hum Exp Toxicol; 2020 Apr; 39(4):537-546. PubMed ID: 31876182
[TBL] [Abstract][Full Text] [Related]
20. Rate of deoxygenation modulates rheologic behavior of sickle red blood cells at a given mean corpuscular hemoglobin concentration.
Kaul DK; Liu XD
Clin Hemorheol Microcirc; 1999; 21(2):125-35. PubMed ID: 10599596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
